There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...
Penn researchers are developing new treatments using mRNA technology to combat a range of diseases, namely celiac disease ...
Immune cell populations of people with post-vaccination syndrome had lower levels of effector CD4 T cells and higher levels ...
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
The vaccine will be administered to girls between the ages of nine and 16 as part of the government’s initiative to address the rising number of cancer cases in the country.